Geneva’s Regional Grants & Contracts Director Kelly Lehner will be attending the eleventh annual Advances in Vaccine Technology Summit in Boston from 7- 8 December. The summit will discuss the continuing involvement and future of vaccine technology. Synthetic vaccine candidates, genomic analysis of disease progression and vaccine response, structure-based antigen design, and nanoparticle delivery systems are just a few of the topics that will be showcased during the event.
As always, Geneva welcomes the opportunity to connect with our current researchers as well as meet new potential partners. Please contact Ms. Lehner for more information about Geneva and our services.
FIND MORE news and events »